Screener
Journey Medical Corporation DERM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$312K+91.8% | -$2.23M+45.2% | -$1.25M— | -$2.32M+3.1% | -$3.8M-12.9% | ||
| $1.44M+7.6% | $989K-25.2% | $1.78M+28.8% | $1.85M+13.0% | $1.34M-20.2% | ||
| —— | $2.91M+203% | -$6.28M— | -$2.38M-106% | -$942K+81.8% | ||
| —— | —— | —— | —— | —— | ||
| $158K-4.2% | $220K-93.9% | $5.43M-48.9% | $7.04M— | $165K-96.7% | ||
| —— | $3.13M+309% | —— | $4.66M+421% | -$777K-436% |
FAQ
- Where does Journey Medical Corporation's cash flow data come from?
- Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
